Salentra in the News
Check out our latest discoveries, product release, and investor-related resources. We are working diligently to launch our new products and services. Company growth and financial related resources are posted here for investment opportunities.
Our SCIslets are provided in different formats to accommodate our customers needs. We provide SCIslets in a single-cell cryopreserved format and as reaggregated clusters.
Our SCIslets are provided in different formats to accommodate our customers needs. We provide SCIslets in a single-cell cryopreserved format and as reaggregated clusters.
News Blog
Salentra Biosciences was awarded funding from Skandalaris
​
April 27, 2021
​
Salentra Biosciences co-founders participated the Skandalaris venture competition and is awarded $7500 to support the establishment of SC-Islet production.
​
​
​
​
​
​
​
​
​
​
​
Salentra acquires new office and lab production space
​
January 30, 2021
​
Salentra Biosciences joined the Biogenerator program in St. Louis and acquired a working lab space and office facility to begin product operations.
​
​
​
​
​
​
​
​
​
​
​
​
​
Licensing agreement signed for Producing SC- Islets
​
October 01, 2020
​
Salentra Biosciences LLC purchased a patent license for generating stem cell derived islets for research use from Washington University in St. Louis.
​
​
Salentra Biosciences LLC is a registered company​
​
June 29, 2020
​
Co-founding members Velazco-Cruz, Augsornworawat, Wernes, and Millman established Salentra Biosciences as an LLC partnership.
​
​
Founding members win pitch competition​
​
June 23, 2020
​
Salentra founder wins initial pitch competition award of $25,000 from the Spring 2020 LEAP (Leadership and Entrepreneurship Acceleration Program) gap fund grant.
​
​
​
​
​
​
​
Publications relating to our technology
Augsornworawat, P., Maxwell, K. G., Velazco-Cruz, L., & Millman, J. R. (2021). Single-cell transcriptome profiling reveals β cell maturation in stem cell-derived islets after transplantation. Cell reports, 34(10), 108850. doi:10.1016/j.celrep.2021.108850
Augsornworawat, P., & Millman, J. R. (2020). Single-cell RNA sequencing for engineering and studying human islets. Current Opinion in Biomedical Engineering. 27-33 doi:10.1016/j.cobme.2020.06.003
Velazco-Cruz, L., Goedegebuure, M. M., & Millman, J. R. (2020). Advances toward engineering functionally mature human pluripotent stem cell-derived β cells. Frontiers in Bioengineering and Biotechnology, 8, 786. doi:10.3389/fbioe.2020.00786
Velazco-Cruz, L., Goedegebuure, M. M., Maxwell, K. G., Augsornworawat, P., Hogrebe, N. J., & Millman, J. R. (2020). SIX2 regulates human β cell differentiation from stem cells and functional maturation in vitro. Cell reports, 31(8), 107687. doi:10.1016/j.celrep.2020.107687
Hogrebe, N. J., Augsornworawat, P., Maxwell, K. G., Velazco-Cruz, L., and Millman, J. R. (2020). Targeting the cytoskeleton to direct pancreatic differentiation of human pluripotent stem cells. Nat. Biotechnol. 38, 460–470. doi:10.1038/s41587-020-0430-6.
Maxwell, K. G., Augsornworawat, P., Velazco-Cruz, L., Kim, M. H., Asada, R., Hogrebe, N. J., et al. (2020). Gene-edited human stem cell–derived β cells from a patient with monogenic diabetes reverse preexisting diabetes in mice. Sci. Transl. Med. 12, eaax9106. doi:10.1126/scitranslmed.aax9106.
Velazco-Cruz, L., Song, J., Maxwell, K. G., Goedegebuure, M. M., Augsornworawat, P., Hogrebe, N. J., et al. (2019). Acquisition of Dynamic Function in Human Stem Cell-Derived β Cells. Stem Cell Reports. doi:10.1016/j.stemcr.2018.12.012.
Augsornworawat, P., Velazco-Cruz, L., Song, J., and Millman, J. R. (2019). Hydrogel platform for in vitro three-dimensional assembly of human stem cell-derived β cells and endothelial cells. Acta Biomater. doi:https://doi.org/10.1016/j.actbio.2019.08.031.